Clinical and pathological features of patients with resected synovial sarcoma: A multicenter retrospective analysis of the Anatolian Society of Medical Oncology


Tarkan Y., Erkan A., Selcuk E. S., Mehmet K., Tugba K. F., Ozlem U. S., ...Daha Fazla

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.10, sa.1, ss.73-78, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10 Sayı: 1
  • Basım Tarihi: 2014
  • Doi Numarası: 10.4103/0973-1482.131381
  • Dergi Adı: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.73-78
  • Anahtar Kelimeler: Ki-67, mitotic activity, synovial sarcoma, PROGNOSTIC-FACTORS, TENDOSYNOVIAL SARCOMA, CHEMOTHERAPY, OUTCOMES, TUMORS, EXTREMITIES, SURVIVAL
  • Gazi Üniversitesi Adresli: Evet

Özet

Background: Synovial sarcoma (SS) is a rare disease and compared with other soft-tissue sarcomas has a relatively high mortality rate. The optimal management of this disease and prognostic factors associated with patient outcome remains controversial.